Alphina Therapeutics
  • Home
  • Team
  • Careers
  • Contact
  • News
Select Page

News

Alphina Therapeutics Strengthens Management Team with Appointment of Marc Damelin, Ph.D. as Chief Scientific Officer

Read more »
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer; Barbara S. Fox, Ph.D., Named Chair of Alphina’s Board of Directors

Read more »
Alphina Therapeuctics Logo

Alphina is developing a best-in-class small molecule NAMPT inhibitor to meaningfully improve the lives of patients across a wide range of solid tumor indications.

  • Home
  • Team
  • Careers
  • Contact
  • News
© 2025 Alphina Therapeutics All Rights Reserved.